✦ LIBER ✦

Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial

✍ Scribed by Jonathan M. Coutinho; José M. Ferro; Susanna M. Zuurbier; Marieke S. Mink; Patrícia Canhão; Isabelle Crassard; Charles B. Majoie; Jim A. Reekers; Emmanuel Houdart; Rob J. de Haan; Marie-Germaine Bousser; Jan Stam

Book ID: 114857129
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 123 KB
Volume: 8
Category: Article
ISSN: 1747-4930
DOI: 10.1111/j.1747-4949.2011.00753.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Catheter-directed Venous Thrombolysis in

Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis-the CaVenT Study: Rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)

✍ Tone Enden; Leiv Sandvik; Nils-Einar Kløw; Geir Hafsahl; Pål Andre Holme; Lars O 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Evaluation of prasugrel compared with cl

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

✍ Stephen D. Wiviott; Elliott M. Antman; C. Michael Gibson; Gilles Montalescot; Je 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Evaluation of prasugrel compared with cl

✍ Stephen D. Wiviott; Elliott M. Antman; C. Michael Gibson; Gilles Montalescot; Je 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Rationale and Design of ATHENA: A Placeb

Rationale and Design of ATHENA: A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter

✍ STEFAN H. HOHNLOSER; STUART J. CONNOLLY; HARRY J.G.M. CRIJNS; RICHARD L. PAGE; W 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

Design and rationale for the Myocardial

Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction

✍ Noémi Nyolczas; Mariann Gyöngyösi; Gilbert Beran; Markus Dettke; Senta Graf; Hei 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB